• 

  After Resurrecting Alzheimer’s Drug, Biogen Seeks to Re-Dose Trial Participants by March 2020
• 

  Doctors React to Biogen Alzheimer’s Drug Reversal: ‘There Is Much Yet to Learn’
• 

  Phil’s Journal: Biogen Cancelled Promising Alzheimer’s Study; Now They’re Bringing It Back
• 

  Biogen Revives Aducanumab, Experimental Alzheimer’s Drug, to Submit for FDA Approval
• 

  Dementia and Diabetes: New Research Delves into the Brain’s Metabolic Function
• 

  Assisted Living Workers Arrested After Filming Dementia Patients Fighting
• 

  Looking Beyond Drugs to Treat Aggression in Dementia Patients
• 

  Changes in Alzheimer’s Disease May Be Detectable In Blood Samples
• 

  8 Evidence-Based Steps to Improving Brain Health (And What Your Doctor May Not Tell You)
• 

  Treating TBI Based on Blood Vessel Damage
• 

  Beta-amyloid Plaques May Appear in the Brain as Early as a Month After Birth
• 

  Caregivers Are Stepping into the Shoes of People With Lewy Body Dementia Through VR
• 

  Antipsychotic Drugs Linked to More Hospitalizations Among Dementia Patients
• 

  Oral Anticoagulants Show Promise in Fighting Alzheimer’s in Mice
• 

  New Study Identifies Protein Linked to Inflammation in Alzheimer’s

Previous112113114Next